Pharmaceuticals in Japan industry profile provides top-line qualitative and quantitative summary information including: market size (value 2017-22, and forecast to 2027). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
Key Highlights
- The pharmaceuticals market consists of ethical drugs only and does not include consumer healthcare or animal healthcare.
- The Japanese pharmaceuticals market had total revenues of $92.3 billion in 2022, representing a compound annual growth rate (CAGR) of 9% between 2017 and 2022.
- 0
- The Japanese market acquired a 21.7% share of the Asia-Pacific pharmaceuticals market in 2022. The Japanese government is aiming to revive its pharmaceutical industry by implementing changes to pricing policies that support access to innovative medicines. The country has reduced the "drug lag" by prioritizing consultation, rapid review, premium drug pricing, and an extended data protection period.
Scope
- Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the pharmaceuticals market in Japan
- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the pharmaceuticals market in Japan
- Leading company profiles reveal details of key pharmaceuticals market players’ global operations and financial performance
- Add weight to presentations and pitches by understanding the future growth prospects of the Japan pharmaceuticals market with five year forecasts
Reasons to Buy
- What was the size of the Japan pharmaceuticals market by value in 2022?
- What will be the size of the Japan pharmaceuticals market in 2027?
- What factors are affecting the strength of competition in the Japan pharmaceuticals market?
- How has the market performed over the last five years?
- What are the main segments that make up Japan's pharmaceuticals market?
Table of Contents
1 Executive Summary
2 Market Overview
3 Market Data
4 Market Segmentation
5 Market Outlook
6 Five Forces Analysis
7 Competitive Landscape
8 Company Profiles
9 Macroeconomic Indicators
10 Appendix
List of Tables
List of Figures
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Daiichi Sankyo Co Ltd
- Astellas Pharma Inc.
- Takeda Pharmaceutical Company Limited
- Mitsubishi Tanabe Pharma Corporation
